Attached files
| file | filename |
|---|---|
| EX-4.1 - DESCRIPTION OF THE REGISTRANT'S SECURITIES - Silo Pharma, Inc. | f10k2020a1ex4-1_silopharma.htm |
| EX-31.2 - CERTIFICATION - Silo Pharma, Inc. | f10k2020a1ex31-2_silopharma.htm |
| EX-31.1 - CERTIFICATION - Silo Pharma, Inc. | f10k2020a1ex31-1_silopharma.htm |
| EX-21.1 - SUBSIDIARIES - Silo Pharma, Inc. | f10k2020a1ex21-1_silopharma.htm |
| 10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Silo Pharma, Inc. | f10k2020a1_silopharmainc.htm |
Exhibit 32.1
Statement of Chief Executive Officer and Chief Financial Officer
Pursuant to Section 1350 of Title 18 of the United States Code
Pursuant to Section 1350 of Title 18 of the United States Code as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Eric Weisblum, the Chief Executive Officer and Chief Financial Officer, of Silo Pharma, Inc. (the “Company”), hereby certifies that based on the undersigned’s knowledge:
1. The Company’s Annual Report on Form 10-K/A for the period ended December 31, 2020 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 17, 2021 | /s/ Eric Weisblum |
| Eric Weisblum | |
| Chief Executive Officer and Chief Financial Officer | |
| (Principal Executive Officer and Principal Financial and Accounting Officer) |